UNCLAIMED
Median Technologies
Overview
Median Technologies is a French company operating within the Computers and Technology sector, specifically focusing on information technology and services. With a workforce of approximately 225 employees and reported revenue of 26 million USD, the company engages in the development of innovative solutions for the healthcare industry. Their published research emphasizes the importance of Blinded Independent Central Review (BICR) in imaging-based clinical trials, particularly in oncology. A recent study highlighted the variability in double-read assessments of disease progression using RECIST 1.1 criteria, which is critical for ensuring the quality of data in clinical trials. The research analyzed data from five clinical trials involving lung cancer patients and revealed significant discordance rates in assessments of progressive disease, underscoring the complexities involved in evaluating treatment responses. Median Technologies' expertise appears to be centered around enhancing the accuracy of clinical trial outcomes through advanced imaging techniques and rigorous review processes, reflecting their commitment to improving oncology research methodologies.